Boehringer Ingelheim Animal Health USA Inc., an animal health company, will create 225 jobs and invest more than $120 million in Gwinnett, Clarke, and Hall counties. The company has located its North American headquarters in Duluth, creating 75 new jobs; is adding more than 100 new jobs at its manufacturing and research and development facility in Athens; and more than 50 jobs at the company’s Gainesville manufacturing facility.
Headquartered in Ingelheim, Germany, Boehringer Ingelheim is a family-owned company, founded in 1885, with a focus on researching, developing, manufacturing, and marketing new medications for human and veterinary medicine.
“For nearly 40 years, the company and its predecessors have helped make the state of Georgia a key player in animal health — from its beginning producing rabies vaccines in Athens, to multiple facilities today, that are playing an instrumental role in advancing animal health and well-being,” said Everett Hoekstra, president of Boehringer Ingelheim Animal Health USA Inc. “Our investments will expand our capabilities and presence in Georgia, and drive future growth and innovation to help prevent disease in livestock and pets.”
Support real journalism. Support local journalism. Subscribe to The Atlanta Journal-Constitution today. See offers.
Your subscription to the Atlanta Journal-Constitution funds in-depth reporting and investigations that keep you informed. Thank you for supporting real journalism.